Fate Therapeutics (FATE) Enterprise Value Growth (5y) (2017 - 2026)
Fate Therapeutics (FATE) Enterprise Value Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fate Therapeutics | 302.48 Mn | 302.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.04% |
| Dec 31, 2025 | 15.86% |
| Sep 30, 2025 | 15.11% |
| Jun 30, 2025 | 16.02% |
| Mar 31, 2025 | -3.41% |
| Dec 31, 2024 | -4.74% |
| Sep 30, 2024 | 0.39% |
| Jun 30, 2024 | -13.48% |
| Mar 31, 2024 | -15.95% |
| Dec 31, 2023 | -9.41% |
| Sep 30, 2023 | -10.61% |
| Jun 30, 2023 | -37.10% |
| Mar 31, 2023 | -35.77% |
| Dec 31, 2022 | -34.01% |
| Sep 30, 2022 | -48.81% |
| Jun 30, 2022 | -51.61% |
| Mar 31, 2022 | -47.46% |
| Dec 31, 2021 | -46.23% |
| Sep 30, 2021 | -70.85% |
| Jun 30, 2021 | -72.21% |